# Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab

> **NCT06234514** · PHASE4 · COMPLETED · sponsor: **Dongyang People's Hospital** · enrollment: 111 (actual)

## Conditions studied

- Macular Cystoid Edema

## Interventions

- **DRUG:** Jueling Mingmu decoction
- **DRUG:** intravitreal injections of 0.5mg ranibizumab

## Key facts

- **NCT ID:** NCT06234514
- **Lead sponsor:** Dongyang People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234514, "Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06234514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*